Toxin for Treating Raynaud Conditions in Hands (The TORCH Study): A Systematic Review and Meta-analysis

Background:. Raynaud disease of the hands is a complex disorder resulting in inappropriate constriction and/or insufficient dilation in microcirculation. There is an emerging role for botulinum toxin type A (BTX-A) in the treatment armamentarium for refractory Raynaud disease. The aim of this system...

Full description

Bibliographic Details
Published in:Plastic and Reconstructive Surgery, Global Open
Main Authors: Ellen Geary, MD, Justin C.R. Wormald, MRCS, PhD, Kevin J. Cronin, MSc, FRCS, Plast, Henk P. Giele, FRACS, MRACMA, Laura Durcan, MD, FRCPI, Oran Kennedy, PhD, Fergal O’Brien, PhD, Roisin T. Dolan, MD, FRCS, Plast
Format: Article
Language:English
Published: Wolters Kluwer 2024-06-01
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005885

Internet

http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005885

Similar Items